Evaluating the Potential of Microdosing 1cp‐LSD for the Treatment of Canine Anxiety: A One‐Month Case Study
Veterinary Medicine and Science · 2025
DOI: 10.1002/vms3.70486 ↗Kurz gefasst
Fallbericht in der Zeitschrift Veterinary Medicine and Science, 2025. Verfasst von Elisa Hernández-Álvarez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary, Universidad de Las Palmas de Gran Canaria, Arucas, Spain. Hauptthemen laut MEDLINE: Anxiety, Dog Diseases, Anti-Anxiety Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This pilot study explored the potential of microdosing 1‐cyclopropionyl‐d‐lysergic acid diethylamide (1cp‐LSD) to treat canine anxiety. A single‐case study was conducted on a 13‐year‐old female dog with severe separation anxiety, who was treated with 5 µg of 1cp‐LSD every 3 days for a month. Anxiety was assessed before, after, and 1 month following treatment using a validated questionnaire. The owner's attachment style was assessed using a validated scale. The dog's anxiety score significantly decreased from 29 (severe) to 14 (moderate) after treatment. A reduction in anxiety levels was observed, characterized by decreased destructive behaviour and shorter durations of vocalization. This improvement was sustained 1 month following treatment, although vocalization frequency increased. These findings suggest potential therapeutic efficacy of microdosing 1cp‐LSD in managing canine anxiety; however, the absence of a control group makes it difficult to determine whether the observed effects are due to 1cp‐LSD, owner bias, or natural variability in the dog's behaviour. Additional studies with blinded protocols and larger sample sizes are necessary to validate these findings and further explore the impact of owner attachment on canine anxiety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Veterinary, Universidad de Las Palmas de Gran Canaria, Arucas, Spain.
- Asociación Científica Psicodélica, Canary Islands, Las Palmas de Gran Canaria, Spain.
- Health Sciences Faculty, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
- Asociación Canaria para el Desarrollo de la Salud a través de la Atención, Las Palmas de Gran Canaria, Spain.
- Faculty of Psychology, Universidad del Atlántico Medio, Las Palmas de Gran Canaria, Spain.
- Human Dog, Canary Islands, Las Palmas de Gran Canaria, Spain.
ORCID-Profile: Tobías Fernández-Borkel, Luis Alberto Henríquez-Hernández
Zitieren
APA
Hernández-Álvarez, E., Borkel, L. F., Rojas-Hernández, J., Quintana-Hernández, D. J., García-Serrano, I., Fernández-Borkel, T., Zumbado, M., & Henríquez-Hernández, L. A. (2025). Evaluating the Potential of Microdosing 1cp‐LSD for the Treatment of Canine Anxiety: A One‐Month Case Study. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.70486
Vancouver
Hernández-Álvarez E, Borkel LF, Rojas-Hernández J, Quintana-Hernández DJ, García-Serrano I, Fernández-Borkel T, et al. Evaluating the Potential of Microdosing 1cp‐LSD for the Treatment of Canine Anxiety: A One‐Month Case Study. Veterinary Medicine and Science. 2025. doi:10.1002/vms3.70486
BibTeX
@article{Hernndezlvarez2025,
author = {Hernández-Álvarez, Elisa and Borkel, Lucas F and Rojas-Hernández, Jaime and Quintana-Hernández, Domingo J and García-Serrano, Ignacio and Fernández-Borkel, Tobías and Zumbado, Manuel and Henríquez-Hernández, Luis Alberto},
title = {Evaluating the Potential of Microdosing 1cp‐LSD for the Treatment of Canine Anxiety: A One‐Month Case Study},
journal = {Veterinary Medicine and Science},
year = {2025},
doi = {10.1002/vms3.70486}
}
EUVIMED